This whitepaper focuses on fragment based drug discovery. It reports on how to ensure both maximum gain of IP and synthesizable compounds. Read about the latest successes Pfizer and Boehringer-Ingelheim had using the FTrees-FragmentSpace technology.
This new section collects BioSolveIT Whitepapers – short and compressed information about recent BioSolveIT products and applications.
BioSolveIT Whitepapers are recommended if you would like to obtain a brief yet visually appealing and understandable overview of outstanding possibilities with selected software in the life science area. They target management and scientists alike.
This whitepaper focuses on fragment based drug discovery. It reports on how to ensure both maximum gain of IP and synthesizable compounds. Read about the latest successes Pfizer and Boehringer-Ingelheim had using the FTrees-FragmentSpace technology.
This is about software for Medicinal Chemists and Modelers alike: The whitepaper introduces a novel concept for rapid improvement of affinities under full visual control. Learn about how to prioritize compounds of a series or to yield prediction hit rates of 70% – as for example Bayer did.